- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT05913544
Lyhyt integroiva ja neurokognitiivinen terapia nuorille aikuisille, joilla on raja-alueen persoonallisuushäiriö (SINTYA)
Lyhyt integroiva ja neurokognitiivinen terapia nuorille aikuisille, joilla on raja-alueen persoonallisuushäiriö: Impulsiivisuuden hallinnan tutkimusmalli
Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
Tutkimuksen yleiskatsaus
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Nîmes, Ranska
- CHU de Nîmes
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Diagnosis of BPD according to DSM-5 criteria and BPQ-80 scale.
- High BPD severity level: ZAN-BPD (score ≥ 18/36).
- Understand, write and read French.
- Be able to understand the nature, purpose and methodology of the study and agree to cooperate during evaluations.
- Have signed the informed consent.
- For minor patients, have signed the parental consent by at least one holder of parental authority.
Exclusion Criteria:
- Refusal to participate.
- Existence of a neurological pathology or cerebral sequelae of organic origin which could affect neurocognitive performance.
- Intelligence quotient < 70.
- Lifetime diagnosis of schizoaffective disorder or schizophrenia (MINI-7).
- Previous or current participation in specific psychotherapy for BPD.
- Subject deprived of liberty (by judicial or administrative decision) and/or protected by law.
- Inclusion in another study including psychotherapy for the duration of the study.
- Inclusion in a drug RIPH1 study or in a REC study (European regulation of clinical trials) for the entire duration of the study.
- Subject in period of exclusion from another research protocol.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Ei väliintuloa: Ohjaus
|
|
|
Kokeellinen: SINTYA ryhmä
|
10-week psychotherapy program consisting of a weekly 1h30 hour group therapy session plus 1 hour individual therapy session |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Variation in explicit impulsivity between groups
Aikaikkuna: Baseline
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Baseline
|
|
Variation in explicit impulsivity between groups
Aikaikkuna: Month 4
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Month 4
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Variation in explicit impulsivity between groups
Aikaikkuna: Month 7
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Month 7
|
|
Variation in impulsiveness between groups
Aikaikkuna: Baseline
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Baseline
|
|
Variation in impulsiveness between groups
Aikaikkuna: Month 4
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Month 4
|
|
Variation in impulsiveness between groups
Aikaikkuna: Month 7
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Month 7
|
|
BPD severity level between groups
Aikaikkuna: Baseline
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Baseline
|
|
BPD severity level between groups
Aikaikkuna: Month 4
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Month 4
|
|
BPD severity level between groups
Aikaikkuna: Month 7
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Month 7
|
|
Emotional regulation capacities between groups
Aikaikkuna: Baseline
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Baseline
|
|
Emotional regulation capacities between groups
Aikaikkuna: Month 4
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Month 4
|
|
Emotional regulation capacities between groups
Aikaikkuna: Month 7
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Month 7
|
|
Dissociative symptoms between groups
Aikaikkuna: Baseline
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Baseline
|
|
Dissociative symptoms between groups
Aikaikkuna: Month 4
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Month 4
|
|
Dissociative symptoms between groups
Aikaikkuna: Month 7
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Month 7
|
|
Aggression between groups
Aikaikkuna: Baseline
|
Aggression Questionnaire (AQ-12) |
Baseline
|
|
Aggression between groups
Aikaikkuna: Month 4
|
Aggression Questionnaire (AQ-12) |
Month 4
|
|
Aggression between groups
Aikaikkuna: Month 7
|
Aggression Questionnaire (AQ-12) |
Month 7
|
|
Ruminations between groups
Aikaikkuna: Baseline
|
Rumination Reflection Questionnaire (RRQ) |
Baseline
|
|
Ruminations between groups
Aikaikkuna: Month 4
|
Rumination Reflection Questionnaire (RRQ) |
Month 4
|
|
Ruminations between groups
Aikaikkuna: Month 7
|
Rumination Reflection Questionnaire (RRQ) |
Month 7
|
|
Number of self-destructive behaviors between groups
Aikaikkuna: Baseline
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Baseline
|
|
Number of self-destructive behaviors between groups
Aikaikkuna: Month 4
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Month 4
|
|
Number of self-destructive behaviors between groups
Aikaikkuna: Month 7
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Month 7
|
|
Number of impulsive behaviors between groups
Aikaikkuna: Baseline
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Baseline
|
|
Number of impulsive behaviors between groups
Aikaikkuna: Month 4
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Month 4
|
|
Number of impulsive behaviors between groups
Aikaikkuna: Month 7
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Month 7
|
|
Level of suicide risk between groups
Aikaikkuna: Baseline
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Baseline
|
|
Level of suicide risk between groups
Aikaikkuna: Month 4
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Month 4
|
|
Level of suicide risk between groups
Aikaikkuna: Month 7
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Month 7
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Aikaikkuna: 12 Months prior to inclusion
|
Information taken from patient medical file |
12 Months prior to inclusion
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Aikaikkuna: Baseline
|
Information taken from patient medical file |
Baseline
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Aikaikkuna: Month 4
|
Information taken from patient medical file |
Month 4
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Aikaikkuna: Month 7
|
Information taken from patient medical file |
Month 7
|
|
Psychosocial functioning between groups
Aikaikkuna: Baseline
|
Functional Assessment Staging Tool (FAST) |
Baseline
|
|
Psychosocial functioning between groups
Aikaikkuna: Month 4
|
Functional Assessment Staging Tool (FAST) |
Month 4
|
|
Psychosocial functioning between groups
Aikaikkuna: Month 7
|
Functional Assessment Staging Tool (FAST) |
Month 7
|
|
Implicit impulsivity between groups
Aikaikkuna: Baseline
|
Continuous Performance Test (CPT) |
Baseline
|
|
Implicit impulsivity between groups
Aikaikkuna: Month 4
|
Continuous Performance Test (CPT) |
Month 4
|
|
Implicit impulsivity between groups
Aikaikkuna: Month 7
|
Continuous Performance Test (CPT) |
Month 7
|
|
Neurocognitive evaluation of implicit impulsivity between groups
Aikaikkuna: Baseline
|
Emotional Stroop (SE) customized to the study |
Baseline
|
|
Neurocognitive evaluation of implicit impulsivity between groups
Aikaikkuna: Month 4
|
Emotional Stroop (SE) customized to the study |
Month 4
|
|
Neurocognitive evaluation of implicit impulsivity between groups
Aikaikkuna: Month 7
|
Emotional Stroop (SE) customized to the study |
Month 7
|
|
Risk taking between groups
Aikaikkuna: Baseline
|
Balloon Analogue Risk Task (BART) |
Baseline
|
|
Risk taking between groups
Aikaikkuna: Month 4
|
Balloon Analogue Risk Task (BART) |
Month 4
|
|
Risk taking between groups
Aikaikkuna: Month 7
|
Balloon Analogue Risk Task (BART) |
Month 7
|
|
Decision making under risk conditions between groups
Aikaikkuna: Baseline
|
Game Dice Task (GDT) |
Baseline
|
|
Decision making under risk conditions between groups
Aikaikkuna: Month 4
|
Game Dice Task (GDT) |
Month 4
|
|
Decision making under risk conditions between groups
Aikaikkuna: Month 7
|
Game Dice Task (GDT) |
Month 7
|
Yhteistyökumppanit ja tutkijat
Tutkijat
- Päätutkija: Clémentine Estric, CHU de Nimes
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- NIMAO/2022-1/CE-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
All IPD that underlie results in a publication
IPD-jaon aikakehys
Upon publication
IPD-jaon käyttöoikeuskriteerit
The IPD will be made available to other researchers upon reasonable request to the corresponding author
IPD-jakamista tukeva tietotyyppi
- STUDY_PROTOCOL
- MAHLA
- ICF
- ANALYTIC_CODE
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .